Untitled 12

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Name: Feda Prelevic | DOB: 7/16/1967 | MRN: 00000000-0472-32BD-7116-D77D8DA682BA | PCP:

SARS-COV-2 RNA, QL NAAT, RT PCR/TMA (COVID-19) -…

SARS-COV-2 RNA, QL NAAT, RT PCR/TMA


(COVID-19)
Results
Abnormal
Status: Final result (Collected: 10/12/2021 12:19 PM)

NAME: Feda Prelevic


MRN: E53089996
DOB: 7/16/1967
Provider Address: CVSMC NY
NORTH WINTON ROAD ROCHESTER COVID - 19 TESTING SITE
185 NORTH WINTON ROAD
ROCHESTER NY 14610
Dept Fax: 401-652-9093
Provider Phone #: 1-866-389-2727

Hello,

You have a POSITIVE Covid-19 Test Result.

If you have a positive test result, it is very likely that you have COVID-19. Therefore, it is
also likely that you may be placed in isolation to avoid spreading the virus to others. There is
a very small chance that this test can give a positive result that is wrong (a false positive
result). Some people who test positive for COVID-19 may be eligible to receive monoclonal
antibody treatment. Patients who have a PCP should talk to their provider to screen for and
order this treatment if indicated. Patients without a PCP can go to an urgent care center or
ER for evaluation. For more information regarding this treatment and to see if it may be
something you could qualify for, see this Patient Fact Sheet .

Component Value Flag Ref Range Units Status


Quest SARS-COV-2 DETECTED NOT DETECTED Final
RNA, QL NAAT, RT
PCR/TMA (COVID-19)
Comment:

A Detected result indicates that the patient's specimen


was positive for SARS-CoV-2 RNA.

Test Method: Nucleic Acid Amplification Test including


reverse transcription polymerase chain reaction (RT-PCR)
and transcription mediated amplification (TMA). The test
method meets the US Centers for Disease Control and
prevention (CDC) pre departure and arrival requirement
for viral test for COVID-19 dated January 28, 2021.
Testing requirements for traveling may change with time.
The patient is responsible for determining the test
requirements for each nation while they are traveling.

This test has been authorized by the FDA under an


Emergency Use Authorization (EUA) for use by authorized
laboratories.

Please review the "Fact Sheets" and FDA authorized


labeling available for health care providers and
patients using the following websites:
https://www.questdiagnostics.com/home/Covid-19/HCP/NAAT/fact-sheet2
https://www.questdiagnostics.com/home/Covid-19/Patients/NAAT/
fact-sheet2

Due to the current public health emergency, Quest


Diagnostics is accepting samples from appropriate
clinical sources collected using wide variety of
swabs and transport media for COVID-19. Not detected
test results derived from specimens received in non-
commercially manufactured viral collection kits or those
not yet authorized by FDA for COVID-19 testing should be
cautiously evaluated and take extra precautions such as
additional clinical monitoring, including collection
of an additional specimen.

Additional information about COVID-19 can be found


at the Quest Diagnostics website:
www.QuestDiagnostics.com/Covid19.

MyChart® licensed from Epic Systems Corporation © 1999 - 2020

You might also like